Urolithiasis Clinical Trial
Official title:
The Effect of Vinegar Consumption on 24-hour Urinary Risk Factors Associated With Calcium Oxalate Urinary Stone Formation: a Randomised Controlled Trial
Purpose:
The aim of this present study is to investigate the effect of vinegar consumption on 24-hour
urinary risk factors associated with calcium oxalate urinary stone formation and blood
biochemical parameters.
Methods:
The investigators will recruit 50 healthy young student volunteers in this study. By simple
random sampling technique, volunteers will be allocated to two groups (group 1, control
group; group 2, vinegar group).Each participant in vinegar group drink 15ml vinegar (
Ninghuafu, Sanxi, China) at noon and evening respectively for a period of four weeks.The end
point of this study is comparison the outcomes of 24-hour urine and blood biochemical
parameters between different group and point-in-time.
Purpose:
The written history of vinegar use in China was more than 5,000 years,and it was used as
health care products since ancient times. In addition of the main component of acetic acid,
it also contains other acids, esters, polyphenols and other active substances.Previous
studies have reported some effects of vinegar, such as delays gastric emptying,relieves
fatigue, regulates blood glucose and lipid metabolism, antioxidant, reduces blood pressure
and so on. The China national epidemiological study of urolithiasis which was conducted from
May 2013 through July 2014 indicated that vinegar may be protective against the formation of
urolithiasis (has not been published). Animal experiments showed that vinegar could inhibit
oxalate calcium crystal formation in rat kidneys (has not been published). Consequently, we
performed this randomized controlled trial to investigate the effect of vinegar consumption
on 24-hour urinary risk factors associated with calcium oxalate urinary stone formation and
blood biochemical parameters.
Methods:
Study design and participants: We will recruit 50 healthy young student volunteers in this
study. The inclusion criteria are male who age 18-35 years, and those with normal renal
function,without urolithiasis and congenital urinary tract abnormalities. The exclusion
criteria include hematuria, urinary tract infection and have a history of kidney or urinary
diversion. We exclude male older than 35 years because usually they have to work and not
easy to collect 24-hour sample. The reason of excluding female is that the trail will last
four weeks and women's menstrual cycle could affect 24-hour urine collection.
Randomisation:
Trained research clinicians enroll volunteers in a university nearby our hospital.
Volunteers will be allocated in a 1:1 ratio to control group(group 1) or vinegar group(group
2) by simple random sampling technique, which is conducted by clinical trial office in
urology department of our hospital in Guangzhou, China.
Procedures: Each participant in vinegar group drink 15ml vinegar ( Ninghuafu, Sanxi, China)
after dinner at noon and evening respectively for a period of four weeks,and participants in
control group do not need intervention.All of participants drink vinegar under the
surveillance of research clinicians.
Data collection:
Baseline data will be collected before randomization in our hospital. The baseline data
protocol includes urinary ultrasonography, spot urine examines, 24-hour urine analysis and
blood chemical examines. The parameters of 24-hour urine analysis include Ph, volume,
creatinine, oxalate, citrate, phosphate, uric acid, calcium, magnesium, sodium and chloride.
The standard blood analysis protocol included routine haematology, fasting serum glucose,
creatinine, urea, uric acid, high-density lipoprotein, low-density lipoprotein,
triglycerides, alanine transaminase(ALT), total protein(TP), albumin, glutamyltransferase
(GGT) , serum total bile acid, cholesterol, sodium, potassium, calcium and chloride ions.
Another tube of blood samples are freeze in -80 degree refrigerator for further analysis of
oxidation of blood protein product(AOPP), malondialdehyde(MDA), glutathion
peroxidase(GSH-PX), superoxide dismutase(SOD) and catalase activity(CAT).
Follow-up data include 24-hour urine analysis on the 7th, 14th, 21th and 28th day during
this period and blood biochemical examines on the 29th day. The protocol of 24-hour urine
and blood chemical examines is the same with baseline data. And participants will be asked
to make a record of meals for seven days.The ANOVA for repeated measures is used to perform
the data analysis.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04746378 -
PRedictive Accuracy of Initial Stone Burden Evaluation.
|
||
Recruiting |
NCT05100017 -
Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure
|
N/A | |
Recruiting |
NCT04021381 -
Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi
|
Phase 3 | |
Completed |
NCT02266381 -
A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy
|
N/A | |
Terminated |
NCT01431378 -
Pilot Study of Model Based Iterative Reconstruction Using 64-Slice
|
N/A | |
Completed |
NCT01451931 -
Study of Tomography of Nephrolithiasis Evaluation
|
Phase 4 | |
Completed |
NCT02895711 -
Radiation Dose of Pediatric Patients During Ureteroscopy
|
||
Completed |
NCT01295879 -
Vitamin D Repletion in Stone Formers With Hypercalciuria
|
Phase 4 | |
Completed |
NCT05340075 -
Staged Bilateral Percutaneous Nephrolithotomy
|
||
Recruiting |
NCT03919227 -
Measurement of Resistance During UAS Insertion Procedure in RIRS
|
N/A | |
Recruiting |
NCT03717285 -
Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS
|
N/A | |
Completed |
NCT05340088 -
Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
|
||
Completed |
NCT05032287 -
Medical Expulsive Therapy Post-SWL For Renal Stones
|
N/A | |
Recruiting |
NCT05701098 -
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
|
N/A | |
Not yet recruiting |
NCT04080973 -
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia
|
N/A | |
Terminated |
NCT01736358 -
The Use of Intranasal Ketoralac for Pain Management (Sprix)
|
Phase 4 | |
Completed |
NCT01792765 -
Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
|
N/A | |
Completed |
NCT06211842 -
Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Not yet recruiting |
NCT04606758 -
Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease
|
N/A |